Hospital Universitario De La Ribera

At Hospital Universitario De La Ribera, research in these areas focuses on major conditions such as atherosclerotic cardiovascular disease, obesity, overweight, and type 2 diabetes mellitus. The trials are designed to assess whether new treatments can improve heart health, support weight management, and better control glucose and related metabolic risks.

• Testing therapies aimed at reducing cardiovascular events and protecting kidney function
• Evaluating treatments for type 2 diabetes and improved glucose control
• Studying new options for obesity and weight reduction

This research also includes studies in people with chronic kidney disease and high cardiovascular risk, reflecting a strong interest in preventing long-term complications.

Clinical trials in this field address endocrine and neurological disorders, including acromegaly and narcolepsy with cataplexy. The main goal is to improve symptom control, enhance day-to-day functioning, and expand treatment choices for patients with chronic hormone-related and sleep-wake disorders.

• Assessing treatments for acromegaly after prior therapy
• Evaluating therapies for narcolepsy type 1 and excessive daytime sleepiness
• Exploring longer-term safety and tolerability of new endocrine and sleep treatments

These studies align closely with the site’s Endocrinology expertise and its focus on patient-centered care for complex chronic conditions.

The oncology research portfolio at this site includes studies in breast cancer, urothelial cancer, colorectal cancer, bladder cancer, and myelofibrosis. These trials are aimed at improving survival outcomes, slowing disease progression, and identifying better treatment strategies for patients with advanced or treatment-resistant disease.

• Testing new combinations for advanced breast cancer
• Evaluating treatment options for metastatic colorectal cancer and urothelial cancer
• Comparing approaches that may improve response monitoring and disease control

The work also includes efforts to refine how treatment effectiveness is measured, helping clinicians better tailor care for people with difficult-to-treat cancers.

Respiratory research at Hospital Universitario De La Ribera centers on chronic obstructive pulmonary disease and eosinophilic asthma. The studies are focused on evaluating biologic and other targeted therapies that may improve symptom control, reduce flare-ups, and support better long-term breathing health.

• Assessing treatments for COPD with type 2 inflammation
• Studying add-on therapies for eosinophilic asthma
• Comparing new options with standard respiratory care

Overall, this respiratory program aims to offer more effective approaches for patients whose disease remains uncontrolled with usual treatment.

In addition to the major therapeutic areas, the site is involved in studies that do not fit neatly into a single category but still address important clinical questions. These include research on vitamin D deficiency, biomarker-based monitoring, and broader efforts to improve how disease activity and treatment response are measured.

• Improving correction of severe vitamin D deficiency
• Using ctDNA to track early treatment response in breast cancer
• Supporting more precise evaluation of treatment benefit across different diseases

These studies show a broad interest in both treatment development and better diagnostic or monitoring tools across the research program.